Details

Proteomic and physicochemical analysis of erythrocyte membrane vesicles from fresh and frozen blood
ID Tomić, Katarina (Author), ID Ivanovski, Sara (Author), ID Šribar, Jernej (Author), ID Čebulj, Daša (Author), ID Žvanut, Samuel (Author), ID Lenassi, Metka (Author), ID Fonović, Marko (Author), ID Križaj, Igor (Author), ID Kostevšek, Nina (Author)

.pdfPDF - Presentation file, Download (10,07 MB)
MD5: EFEFD4C82C3173426EDAE927DF2BE8FD
URLURL - Source URL, Visit https://pubs.acs.org/jprobs/article/doi/10.1021/acs.jproteome.6c00535/5426715/Proteomic-and-Physicochemical-Analysis-of This link opens in a new window

Abstract
Erythrocyte membrane vesicles (EMVs) have emerged as promising nanocarriers for drug delivery due to their biocompatibility and immune evasion through retention of erythrocyte surface proteins. The main limitation is their dependence on freshly drawn blood, which limits batch production. Long-term storage of EDTA-anticoagulated blood at −80°C without cryoprotectant represents an accessible alternative, but its effect on EMV physicochemical properties and protein composition has not been investigated. We prepared EMVs from fresh and frozen blood and characterized the resulting fractions by dynamic light scattering, nano-flow cytometry, cryo-transmission electron microscopy, negative staining transmission electron microscopy, and quantitative mass spectrometry-based proteomics. EMV size, surface charge, and morphology did not differ significantly between fresh and frozen preparations. Extrusion effectively normalized particle size despite increased heterogeneity in frozen ghost cell fractions, and both preparations yielded structurally intact vesicles after ultracentrifugation. At the proteomic level, freezing reduced proteomic complexity in membrane fractions and selectively depleted cytosol-associated proteins. The core membrane proteome, including Band 3, remained stable. However, glycophorin A showed the largest reduction in frozen preparations, and CD47 levels were reduced in the ultracentrifuged fraction. These differences may be critical for applications where preservation of specific surface proteins is required, such as immune evasion or targeted drug delivery. In some cases, frozen blood is potentially a viable source for EMV production when immediate processing is not feasible.

Language:English
Keywords:membrane vesicles, erythrocyte membrane vesicles, blood storage, proteomics, electron microscopy, nano-flow cytometry, membranes, vesicles, peptides, proteins, cells, anatomy
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FKKT - Faculty of Chemistry and Chemical Technology
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:Str. 5534-5548
Numbering:Vol. 25, iss. 10
PID:20.500.12556/RUL-189719 This link opens in a new window
UDC:577
ISSN on article:1535-3907
DOI:10.1021/acs.jproteome.6c00535 This link opens in a new window
COBISS.SI-ID:291636483 This link opens in a new window
Publication date in RUL:13.10.2026
Views:42
Downloads:10
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of proteome research
Shortened title:J. proteome res.
Publisher:American Chemical Society
ISSN:1535-3907
COBISS.SI-ID:513576473 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:membranski vezikli, kri, eritrociti

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0140
Name:Proteoliza in njena regulacija pri zdravju in boleznih

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0170
Name:Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0207
Name:Toksini in biomembrane

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0084
Name:Nanostrukturni materiali

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J4-50150
Name:Eritrocitne membrane kot nanonosilci za gensko terapijo za zdravljenje raka

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J4-70159
Name:TheraPIK3 - ciljno dvojno zdravljenje raka dojke z mutacijo PIK3CA z uporabo siRNK in biomimetičnih dostavnih sistemov

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:PR-13234

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:I0-0003
Name:Infrastrukturna dejavnost KI

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back